At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Adenosine A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders
Most Recent Events
- 08 Dec 2000 Preclinical development for Anxiety disorders in Mexico (Unknown route)